ArticleJournal of the American Chemical Society2021
Host-Guest Induced Peptide Folding with Sequence-Specific Structural Chirality.
Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 41 citations in OpenAlex.
- Article
- Nanomolar Affinity Host-Dye Reporter Pairs from Fluorescently Labeled Oligoarginine Peptides and p-Sulfonatocalix[4]arene.Chembiochem : a European journal of chemical biology · 2026Article
- Synergy-Promoted Specific Alkyltriphenylphosphonium Binding to CB[8].The Journal of organic chemistry · 2025Article
- Supramolecular rosette intermediated homochiral double helix.Nature communications · 2025Article
- Configurationally Stepping Confinement Achieved Tunable Chiral Near-Infrared Luminescence Supramolecular Phenothiazine Organic Framework.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Biomimetic Entropy-Dominant Molecular Hinges with Picomolar Affinity.Journal of the American Chemical Society · 2024Article
- Peptide recognition by a synthetic receptor at subnanomolar concentrations.Chemical science · 2024Article
- Cucurbit[8]uril Binds Nonterminal Dipeptide Sites with High Affinity and Induces a Type II β-Turn.Journal of the American Chemical Society · 2024Article
- "Gear-driven"-type chirality transfer of tetraphenylethene-based supramolecular organic frameworks for peptides in water.Chemical science · 2024Article
- A Closed Cavity Strategy for Selective Dipeptide Binding by a Polyaromatic Receptor in Water.JACS Au · 2023Article
- Biomimetic Sequence-Templating Approach toward a Multiscale Modulation of Chromogenic Polymer Properties.Macromolecules · 2023Article
- Chiral adaptive recognition with sequence specificity of aromatic dipeptides in aqueous solution by an achiral cage.Chemical science · 2023Article
- On-Resin Recognition of Aromatic Oligopeptides and Proteins through Host-Enhanced Heterodimerization.Journal of the American Chemical Society · 2022Article
- Design and recognition of cucurbituril-secured platinum-bound oligopeptides.Chemical science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Controlling the spatial and temporal behavior of peptide segments is essential in the fabrication of functional peptide-based materials and nanostructures. To achieve a desired structure, complex sequence design is often required, coupled with the inclusion of unnatural amino acids or synthetic modifications. Herein, we investigate the structural properties of 1:1 inclusion complexes between specific oligopeptides and cucurbit[8]uril (CB[8]), inducing the formation of turns, and by alteration of the peptide sequence, tunable structural chirality. We also explore extended peptide sequence binding with CB[8], demonstrating a simple approach to construct a peptide hairpin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.